sharon sanders
Editor-in-Chief & President
Exclusive interview with co-founder John Brownstein and the full history of HealthMap in one timeline visualization.
Thursday 22nd of January 2015by Ben Heubl
snip
nuviun: In October, Epidemico Inc., owner of HealthMap, was acquired by Booz Allen Hamilton. First of call, congratulations. Are there any consequences?
John Brownstein: We are an academic research group at Harvard Medical from Boston Children's Hospital, running a research group to do R&D and public health research. We spun off an entity called Epidemico Inc. that commercializes the licensing of our technology. This way we can be dealing much more with the commercial side, dealing with data sales, and it allows us to develop tools for the government. That company was bought by Booz Allen which opens great opportunities. It allows us to go to places we would have otherwise never gone to and it is good for our infrastructure in order to scale up.
http://nuviun.com/content/blog/healt...-public-health
------------------------------------------------
"Epidemico, with a staff of industry recognized epidemiologists and health leaders, is known for pioneering global population health solutions that radically disrupt traditional detection, reporting and engagement systems. For example, one of Epidemico’s commercially licensed products, HealthMap, leads the field in digital disease detection tracking over 200 infectious diseases worldwide in 15 different languages."
http://www.boozallen.com/media-cente...-epidemico-inc
"Booz Allen?s major clients include global corporations in the health, energy, and financial services sectors, as well as nearly all departments and agencies across the U.S. federal government."
http://www.boozallen.com/consultants
Thursday 22nd of January 2015by Ben Heubl
snip
nuviun: In October, Epidemico Inc., owner of HealthMap, was acquired by Booz Allen Hamilton. First of call, congratulations. Are there any consequences?
John Brownstein: We are an academic research group at Harvard Medical from Boston Children's Hospital, running a research group to do R&D and public health research. We spun off an entity called Epidemico Inc. that commercializes the licensing of our technology. This way we can be dealing much more with the commercial side, dealing with data sales, and it allows us to develop tools for the government. That company was bought by Booz Allen which opens great opportunities. It allows us to go to places we would have otherwise never gone to and it is good for our infrastructure in order to scale up.
http://nuviun.com/content/blog/healt...-public-health
------------------------------------------------
"Epidemico, with a staff of industry recognized epidemiologists and health leaders, is known for pioneering global population health solutions that radically disrupt traditional detection, reporting and engagement systems. For example, one of Epidemico’s commercially licensed products, HealthMap, leads the field in digital disease detection tracking over 200 infectious diseases worldwide in 15 different languages."
http://www.boozallen.com/media-cente...-epidemico-inc
"Booz Allen?s major clients include global corporations in the health, energy, and financial services sectors, as well as nearly all departments and agencies across the U.S. federal government."
http://www.boozallen.com/consultants
Last edited:
